サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：輸血診断の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2023年～2030年
市場調査レポート
商品コード
1321327

輸血診断の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2023年～2030年

Blood Transfusion Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents & Kits), By Application, By End-use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 130 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
輸血診断の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年07月03日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

輸血診断市場の成長と動向

Grand View Research, Inc.の最新レポートによると、輸血診断の世界市場規模は2023年から2030年にかけてCAGR 5.8%で拡大し、2030年には69億6,000万米ドルに達すると予測されています。

輸血診断検査は、輸血前に血液とその成分に対して行われるスクリーニング検査で、患者に感染症が伝播しないことを確認します。貧血や血小板減少症などの血液関連疾患の発生率の増加が輸血の必要性を高めています。例えば、WHOが2023年6月に発表した推計によると、低所得国では輸血総量の54％近くが5歳以下の小児に必要とされているのに対し、高所得国では輸血総量の76％が60歳以上の成人に必要とされています。患者層と血液必要量の増加も市場成長の原動力になると予想されます。

さらに、各国で献血活動を組織し促進するためにいくつかの取り組みが行われているため、献血に対する意識が高まっています。血液の適合性を評価し、すでに感染していないことを確認することは不可欠であるため、市場成長の原動力になると予想されます。このような措置は、特に輸血感染症の頻度が高い発展途上国では、様々な疾患の早期発見と治療にも役立ちます。さらに、技術の進歩、政府の取り組み、研究開発への投資の増加など、その他のいくつかの要因によっても市場は成長すると予想されます。

COVID-19パンデミックは輸血診断業界に大きな影響を与えました。人々の移動が制限されたため、献血活動が中止され、献血数に悪影響を及ぼしました。例えば、2021年11月にPubMedが発表した研究によると、COVID-19の流行時には献血比率が40％から67％減少しました。

パンデミックは世界のサプライチェーンも混乱させ、COVID-19自体の影響を軽減することに主眼が置かれたため、これらの診断検査に必要な医療機器の生産と流通にも影響を及ぼしました。しかし、規制が緩和されたため、多くの国で献血を奨励する革新的なキャンペーンが実施されました。例えば、2021年6月に世界保健機関（WHO）が発表した記事によると、ウガンダ輸血サービス（UBTS）はコールセンターを設置し、より多くのドナーにアプローチするために様々なソーシャルメディアプラットフォームを利用し、ドナー募集のための用途も作成しました。

輸血診断市場レポートハイライト

  • 製品別では、試薬・キットセグメントが2022年に最大の売上シェアを占めました。これは、ドナーのスクリーニングのために入手しやすく、繰り返し購入できることによります。
  • また、試薬・キットセグメントは、認知度の向上に伴いドナー数やスクリーニング数が増加するため、予測期間中に最も速い速度で成長すると予想されます。
  • 用途別では、疾患スクリーニングセグメントが2022年に最大の売上シェアを占めました。輸血感染症の増加により、受血者への合併症を避けるためにより多くのスクリーニングが求められるからです。
  • 最終用途セグメントでは、血液銀行が2022年の市場を独占しました。このセグメントの成長は、血液関連疾患の有病率の増加とそれに伴う血液スクリーニングの必要性に起因しています。
  • 2022年、北米は、同地域における認知度の向上と注目すべき可処分所得により、収益シェアで市場を独占しました。一方、アジア太平洋地域は、輸血感染症の流行と献血に関する意識の高まりにより、予測期間中に最も速いCAGRで成長すると予測されています。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報調達
  • 情報またはデータ分析
  • 市場の形成と検証
  • モデル詳細
  • 二次情報のリスト
  • 一次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

第3章 輸血診断市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 輸血診断市場分析ツール
    • 業界分析- ポーター
    • PESTEL分析

第4章 輸血診断：製品の推定・動向分析

  • 輸血診断市場：重要なポイント
  • 輸血診断市場：動向と市場シェア分析、2022年および2030年
  • 試薬・キット
  • 機器
  • その他

第5章 輸血診断：用途の推定・動向分析

  • 輸血診断市場：重要なポイント
  • 輸血診断市場：動向と市場シェア分析、2022年および2030年
  • 血液型判定
  • 疾患スクリーニング

第6章 輸血診断：最終用途の推定・動向分析

  • 輸血診断市場：重要なポイント
  • 輸血診断市場：動向と市場シェア分析、2022年および2030年
  • 病院
  • 血液銀行
  • 診断研究所
  • その他

第7章 輸血診断市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別の輸血診断市場：マーケットプレースの重要なポイント
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 最近の動向と影響分析、主要市場参入企業別
  • 市場参入企業の分類
    • Grifols
    • Bio-Rad Laboratories, inc.
    • F.Hoffman-La Roche AG
    • Quotient Limited
    • Abbott
    • Ortho Clinical Diagnostics
    • BIOMERIEUX
    • Siemens Healthcare Private Limited
    • MedGenome
    • Beckman Coulter
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America blood transfusion diagnostics market, by End-use, 2018 - 2030 (USD Million)
  • Table 5 North America blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 France blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24 France blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 44 China blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 45 China blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 46 China blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 India blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 India blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Thailand blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 55 Thailand blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Latin America blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 Latin America blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Latin America blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 63 Brazil blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 64 Brazil blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Brazil blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Mexico blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Mexico blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 68 Mexico blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Argentina blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 70 Argentina blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 71 Argentina blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 76 South Africa blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 77 South Africa blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 78 South Africa blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 UAE blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 UAE blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 84 UAE blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 86 Kuwait blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 87 Kuwait blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Blood transfusion diagnostics: market outlook
  • Fig. 9 Blood transfusion diagnostics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Blood transfusion diagnostics market driver impact
  • Fig. 15 Blood transfusion diagnostics market restraint impact
  • Fig. 16 Blood transfusion diagnostics market Strategic initiatives analysis
  • Fig. 17 Blood transfusion diagnostics market: Product movement analysis
  • Fig. 18 Blood transfusion diagnostics market: Product outlook and key takeaways
  • Fig. 19 Reagents & kits market estimates and forecasts, 2018 - 2030
  • Fig. 20 Instruments market estimates and forecasts, 2018 - 2030
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030
  • Fig. 22 Blood transfusion diagnostics market: Application movement analysis
  • Fig. 23 Blood transfusion diagnostics market: Application outlook and key takeaways
  • Fig. 24 Blood grouping market estimates and forecasts, 2018 - 2030
  • Fig. 25 Disease screening market estimates and forecasts, 2018 - 2030
  • Fig. 26 Blood transfusion diagnostics market: End-use movement analysis
  • Fig. 27 Blood transfusion diagnostics market: End-use outlook and key takeaways
  • Fig. 28 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 29 Blood banks market estimates and forecasts, 2018 - 2030
  • Fig. 30 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030
  • Fig. 32 Global blood transfusion diagnostics market: Regional movement analysis
  • Fig. 33 Global blood transfusion diagnostics market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 37 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 40 France market estimates and forecasts, 2018 - 2030
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 48 China market estimates and forecasts, 2018 - 2030
  • Fig. 49 India market estimates and forecasts, 2018 - 2030
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 57 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-4-68038-855-8

Blood Transfusion Diagnostics Market Growth & Trends

The global blood transfusion diagnostics market size is expected to reach USD 6.96 billion by 2030, expanding at 5.8% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Blood transfusion diagnostics tests are screening tests performed on blood and its components before transfusion to ensure no infections are transmitted to the patient. An increase in the incidence of several blood-related diseases such as anemia and thrombocytopenia is driving the need for blood transfusion. For instance, according to the estimates of WHO released in June 2023, nearly 54% of total blood transfusions are needed for children below five years of age in low-income countries whereas 76% of total transfusions in high-income countries are needed for adults over 60 years of age. The increase in the patient group and blood requirement is also expected to drive market growth.

Moreover, there is an increased awareness regarding blood donation owing to several initiatives taken to organize and promote blood drives across countries. It is expected to drive market growth as it is essential to assess the compatibility of blood and ensure it is not already infected. Such steps also help in the early detection and treatment of various diseases, especially among less developed countries where the frequency of transfusion-transmitted diseases is higher. Furthermore, the market is expected to grow owing to several other factors such as technological advancements, government initiatives, and increasing investment in research and development.

The COVID-19 pandemic had a significant impact on the blood transfusion diagnostics industry. Since there were restrictions on people's movement, it led to the cancellation of blood drives and negatively impacted the number of blood donations. For instance, according to a study published by PubMed in November 2021, the ratio of blood donation decreased by 40% to 67% during the COVID-19 outbreak.

The pandemic also disrupted global supply chains, which affected the production and distribution of medical devices needed for these diagnostics tests since the majority of focus was devoted to reducing the impact of COVID-19 itself. However, many countries organized innovative campaigns to encourage blood donations as restrictions were eased. For instance, in an article published by the World Health Organization in June 2021, Uganda Blood Transfusion Service (UBTS) created a call center, used various social media platforms to reach out to more donors, and an application was also created to recruit donors.

Blood Transfusion Diagnostics Market Report Highlights

  • Based on product, the reagents & kits segment accounted for the largest revenue share in 2022, owing to their availability and repetitive purchases for the screening of donors
  • The reagents & kits segment is also expected to grow at the fastest rate during the forecast period, as the number of donors and screenings increase with increasing awareness
  • Based on application, the disease screening segment accounted for the largest revenue share in 2022, as an increase in the transfusion-transmitted infection demands more screenings to avoid any complications to the receiver
  • In the end-use segment, blood banks dominated the market in 2022. The growth of this segment can be attributed to the increasing prevalence of blood-related diseases and subsequently, the need for blood screening derived from it
  • In 2022, North America dominated the market in terms of revenue share owing to increasing awareness and notable disposable income in the region. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period due to the prevalence of transfusion-transmitted diseases and growing awareness regarding blood donation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5 Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Blood Transfusion Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. The increasing prevalence of chronic diseases
      • 3.4.1.2. Rising demand for donor screening
      • 3.4.1.3. Rising number of road & trauma accident cases and surgeries
      • 3.4.1.4. Growing initiatives for blood donation campaigns
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Lack of sufficient blood donations as compared to demand.
  • 3.5. Blood Transfusion Diagnostics Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. The threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Blood Transfusion Diagnostics: Product Estimates & Trend Analysis

  • 4.1. Blood Transfusion Diagnostics Market: Key Takeaways
  • 4.2. Blood Transfusion Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Reagents & kits
    • 4.3.1. Reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Blood Transfusion Diagnostics: Application Estimates & Trend Analysis

  • 5.1. Blood Transfusion Diagnostics Market: Key Takeaways
  • 5.2. Blood Transfusion Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Blood Grouping
    • 5.3.1. Blood grouping market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Disease Screening
    • 5.4.1. Disease screening estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Serological disease screening
      • 5.4.2.1. Blood transfusion diagnostics market for serological disease screening estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Molecular disease screening
      • 5.4.3.1. Blood transfusion diagnostics market for molecular disease screening

Chapter 6. Blood Transfusion Diagnostics: End-use Estimates & Trend Analysis

  • 6.1. Blood Transfusion Diagnostics Market: Key Takeaways
  • 6.2. Blood Transfusion Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Blood Banks
    • 6.4.1. Blood banks market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Laboratories
    • 6.5.1. Diagnostics laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Blood Transfusion Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Blood Transfusion Diagnostics Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Grifols
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Bio-Rad Laboratories, inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. F.Hoffman-La Roche AG
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Quotient Limited
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Abbott
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Ortho Clinical Diagnostics
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. BIOMERIEUX
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Siemens Healthcare Private Limited
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. MedGenome
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Beckman Coulter
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives